The Cost-Effectiveness of Frontline Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia: In Pursuit of Treatment-Free Remission and Dose Reduction.

Saved in:
Bibliographic Details
Title: The Cost-Effectiveness of Frontline Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia: In Pursuit of Treatment-Free Remission and Dose Reduction.
Authors: Metsemakers, Sanne J.J.P.M.1 (AUTHOR) Sanne.Metsemakers@radboudumc.nl, Hermens, Rosella P.M.G.2 (AUTHOR), Ector, Geneviève I.C.G.1 (AUTHOR), Blijlevens, Nicole M.A.1 (AUTHOR), Govers, Tim M.3,4 (AUTHOR)
Source: Value in Health. Feb2025, Vol. 28 Issue 2, p224-232. 9p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2024.12.005